SCHEMBL5267956

SCHEMBL5267956

Cc1[nH]nc(-c2ccc(S(N)(=O)=O)cc2)c1C1=COC=C(C2=CC=CCC2)O1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 19/20 0.41
TTK P33981 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5268022 0.83 CHEK1 (0.31) LRRK2
SCHEMBL5267152 0.80 HSP90AA1 (0.38)
SCHEMBL5269531 0.80 KDM4E (0.42)
SCHEMBL5266777 0.76 HSP90AA1 (0.33)
SCHEMBL5269715 0.76 LRRK2 (0.35) LRRK2
SCHEMBL5269354 0.76 HSP90AA1 (0.48)
SCHEMBL5271929 0.76 HSP90AA1 (0.47)
SCHEMBL5272531 0.75 CHEK1 (0.40) LRRK2TTK
SCHEMBL5272249 0.75 MEN1 (0.39)
SCHEMBL5273258 0.75 HSP90AA1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1456180-B1 3-(2,4)DIHYDROXYPHENYL-4-PHENYLPYRAZOLES AND THEIR MEDICAL USE VERNALIS CAMBRIDGE LTD (GB) 2007-10-03 EP disclosed
US-7247734-B2 3,4-diarylpyrazoles and their use in the therapy of cancer VERNALIS (CAMBRIDGE) LIMITED (GB) 2007-07-24 US disclosed
EP-1456180-A1 3,4-DIARYLPYRAZOLES AND THEIR USE IN THE THERAPY OF CANCER Vernalis (Oxford) Ltd (GB) 2004-09-15 EP disclosed
WO-2003055860-A1 3,4-DIARYLPYRAZOLES AND THEIR USE IN THE THERAPY OF CANCER VERNALIS (CAMBRIDGE) LIMITED (GB) 2003-07-10 WO disclosed